Miltsch Sandra M, Krücken Jürgen, Demeler Janina, Ramünke Sabrina, Harder Achim, von Samson-Himmelstjerna Georg
Institute for Parasitology and Tropical Veterinary Medicine, Freie Universität Berlin, Berlin, Germany.
Parasitol Int. 2013 Dec;62(6):591-8. doi: 10.1016/j.parint.2013.05.006. Epub 2013 May 24.
Due to the increasing development of anthelmintic resistance in nematodes worldwide, it is important to search for anthelmintic compounds with new modes of action and also to investigate the possibility to combine compounds with possible synergistic effects. There might also be the chance to take advantage of the fact that nematode populations which have developed resistance against one anthelmintic class might respond hypersusceptibly to another drug class. The aim of this study was to investigate responses of Caenorhabditis elegans populations with mutations in neuro-muscular ion channels to different anthelmintic classes. Furthermore, potential synergistic effects between two anthelmintic compounds from different classes, i.e. emodepside and tribendimidine, were studied. Although there was neither a synergistic nor an antagonistic effect between emodepside and tribendimidine, other types of interactions could be identified. The C. elegans GABAA-receptor (GABAA-R) unc-49 mutants, showing decreased emodepside susceptibility, were more susceptible to tribendimidine than wild-type C. elegans. In contrast, the reverse phenomenon - hypersusceptibility to emodepside in tribendimidine resistant acetylcholine-receptor (AChR) loss of function mutants - was not observed. Moreover, the slo-1 mutant strain (completely emodepside resistant) also showed hypersusceptibility to piperazine. Interestingly, neither the GABAA-R unc-49 mutants nor the AChR mutants showed decreased susceptibility against piperazine, although there were some studies that indicated an involvement of GABAA-R or AChR in the piperazine mode of action. In conclusion, the present study provides evidence suggesting that interactions between commercially available anthelmintic drugs with different modes of action might be a relatively common phenomenon but this has to be carefully worked out for each anthelmintic and each anthelmintic drug combination. Moreover, results obtained in C. elegans will have to be confirmed using parasitic nematodes in the future.
由于全球范围内线虫对驱虫药的抗药性不断增强,寻找具有新作用模式的驱虫化合物以及研究化合物联合使用产生协同效应的可能性非常重要。此外,还有可能利用对线虫群体已经产生了对一种驱虫药的抗性,可能会对另一种药物高度敏感这一事实。本研究的目的是调查神经肌肉离子通道发生突变的秀丽隐杆线虫群体对不同种类驱虫药的反应。此外,还研究了两种不同种类的驱虫化合物,即埃莫昔泮和三苯双脒之间的潜在协同效应。虽然埃莫昔泮和三苯双脒之间既没有协同作用也没有拮抗作用,但可以识别出其他类型的相互作用。秀丽隐杆线虫GABAA受体(GABAA-R)unc-49突变体对埃莫昔泮的敏感性降低,但比对野生型秀丽隐杆线虫对三苯双脒更敏感。相反,未观察到相反的现象,即对三苯双脒耐药的乙酰胆碱受体(AChR)功能丧失突变体对埃莫昔泮高度敏感。此外,slo-1突变株(对埃莫昔泮完全耐药)对哌嗪也表现出高度敏感性。有趣的是,GABAA-R unc-49突变体和AChR突变体对哌嗪的敏感性均未降低,尽管有一些研究表明GABAA-R或AChR参与了哌嗪的作用模式。总之,本研究提供的证据表明,具有不同作用模式的市售驱虫药之间的相互作用可能是一种相对常见的现象,但必须针对每种驱虫药和每种驱虫药组合进行仔细研究。此外,未来必须使用寄生线虫来证实秀丽隐杆线虫的研究结果。